Modeling Lewy pathology propagation in Parkinson's disease

Parkinsonism and Related Disorders

Volumn 20, Issue SUPPL.1, 2014, Pages

  Luk, Kelvin C ^a   Lee, Virginia M Y ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Synuclein; Parkinson's disease; Propagation; Protein misfolding

Indexed keywords

ALPHA SYNUCLEIN;

ARTICLE; BRAIN NERVE CELL; DISEASE TRANSMISSION; DOWN REGULATION; HUMAN; INNERVATION; LEWY BODY; NEUROANATOMY; NEUROPATHOLOGY; NONHUMAN; PARKINSON DISEASE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MISFOLDING; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA; SYNUCLEINOPATHY;

PARKINSON'S DISEASE; PROPAGATION; PROTEIN MISFOLDING; Α-SYNUCLEIN;

ALPHA-SYNUCLEIN; ANIMALS; DISEASE PROGRESSION; HUMANS; LEWY BODIES; LEWY BODY DISEASE; MODELS, BIOLOGICAL; PARKINSON DISEASE; PROTEOSTASIS DEFICIENCIES;

EID: 84887984409     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/S1353-8020(13)70022-1     Document Type: Article

References (29)

1. Poulopoulos M, Levy O, Alcalay R The neuropathology of genetic Parkinson's disease. Mov Disord 2012, 27(7):831-842.
2. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003, 24(2):197-211.
3. Harding AJ, Broe GA, Halliday GM Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe. Brain 2002, 125(Pt 2):391-403.
4. Irwin DJ, White MT, Toledo JB, Xie SX, Robinson JL, Van Deerlin V, et al. Neuropathologic substrates of Parkinson disease dementia. Ann Neurol 2012, 72(4):587-598.
5. Jellinger KA A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders. Biochim Biophys Acta 2009, 1792(7):730-740.
6. Burke RE, Dauer WT, Vonsattel JP A critical evaluation of the Braak staging scheme for Parkinson's disease. Ann Neurol 2008, 64(5):485-491.
7. Halliday GM, Del Tredici K, Braak H Critical appraisal of brain pathology staging related to presymptomatic and symptomatic cases of sporadic Parkinson's disease. J Neural Transm Suppl 2006, (70):99-103.
8. Dickson D, Uchikado H, Fujishiro H, Tsuboi Y Evidence in favor of Braak staging of Parkinson's disease. Mov Disord 2010, 25(Suppl 1):82.
9. Braak H, Rub U, Gai WP, Del Tredici K Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm 2003, 110(5):517-536.
10. Kordower JH, Chu Y, Hauser RA, Freeman TB, Olanow CW Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease. Nat Med 2008, 14(5):504-506.
11. Hardy J, Cai HB, Cookson MR, Gwinn-Hardy K, Singleton A Genetics of Parkinson's disease and parkinsonism. Ann Neurol 2006, 60(4):389-398.
12. Burre J, Sharma M, Tsetsenis T, Buchman V, Etherton MR, Sudhof TC Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro. Science 2010, 329(5999):1663-1667.
13. Maroteaux L, Campanelli JT, Scheller RH Synuclein - A neuron-specific protein localized to the nucleus and presynaptic nerve-terminal. J Neurosci 1988, 8(8):2804-2815.
14. Hasegawa M, Fujiwara H, Nonaka T, Wakabayashi K, Takahashi H, Lee VMY, et al. Phosphorylated alpha-synuclein is ubiquitinated in alpha-synucleinopathy lesions. J Biol Chem 2002, 277(50):49071-49076.
15. Giasson BI, Duda JE, Murray IVJ, Chen QP, Souza JM, Hurtig HI, et al. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science 2000, 290(5493):985-989.
16. Li W, West N, Colla E, Pletnikova O, Troncoso JC, Marsh L, et al. Aggregation promoting C-terminal truncation of alpha-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations. Proc Natl Acad Sci U S A 2005, 102(6):2162-2167.
17. Ren PH, Lauckner JE, Kachirskaia I, Heuser JE, Melki R, Kopito RR Cytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregates. Nat Cell Biol 2009, 11(2):219-225.
18. Luk K, Song C, O'Brien P, Stieber A, Branch J, Brunden K, et al. Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells. Proc Natl Acad Sci U S A 2009, 106(47):20051-20056.
19. Volpicelli-Daley L, Luk K, Patel T, Tanik S, Riddle D, Stieber A, et al. Exogenous α-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron 2011, 72(1):57-71.
20. Giasson BI, Duda JE, Quinn SM, Zhang B, Trojanowski JQ, Lee VMY Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein. Neuron 2002, 34(4):521-533.
21. Mougenot AL, Nicot S, Bencsik A, Morignat E, Verchere J, Lakhdar L, et al. Prion-like acceleration of a synucleinopathy in a transgenic mouse model. Neurobiol Aging 2012, 33(9):2225-2228.
22. Luk K, Kehm V, Zhang B, O'Brien P, Trojanowski J, Lee V Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice. J Exp Med 2012, 209(5):975-986.
23. Luk K, Kehm V, Carroll J, Zhang B, O'Brien P, Trojanowski J, et al. Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in non-transgenic mice. Science 2012, 338(6109):949-953.
24. Masuda-Suzukake M, Nonaka T, Hosokawa M, Oikawa T, Arai T, Akiyama H, et al. Prion-like spreading of pathological alpha-synuclein in brain. Brain 2013, 136(Pt 4):1128-1138.
25. Angot E, Steiner JA, Hansen C, Li JY, Brundin P Are synucleinopathies prion-like disorders?. Lancet Neurol 2010, 9(11):1128-1138.
26. Wang Y, Shi M, Chung KA, Zabetian CP, Leverenz JB, Berg D, et al. Phosphorylated alpha-synuclein in Parkinson's disease. Sci Transl Med 2012, 4(121):121ra20.
27. Tokuda T, Qureshi MM, Ardah MT, Varghese S, Shehab SA, Kasai T, et al. Detection of elevated levels of alpha-synuclein oligomers in CSF from patients with Parkinson disease. Neurology 2010, 75(20):1766-1772.
28. Guo JL, Covell DJ, Daniels JP, Iba M, Stieber A, Zhang B, et al. Distinct alpha-synuclein strains differentially promote tau inclusions in neurons. Cell 2013, 154(1):103-117.
29. Jucker M, Walker L Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders. Ann Neurol 2011, 70(4):532-540.